Back to Trades
Total Value
$161.6K
Net $161.6K sold
Filing Date
Apr 20, 2026
6 transactions
Sales
$161.6K
6 transactions
Trade Summary
On Apr 17, 2026, MATA NATHAN L., Insider, sold $161.6K of BELITE BIO, INC (BLTE) across 6 transactions. The filing covers company securities and reflects net selling of $161.6K. Reported prices ranged from $158.46 to $163.32. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- BELITE BIO, INC
- Ticker Symbol
- BLTE
- CIK
- 0001889109
Insider Information
- Name
- MATA NATHAN L.
- Role
- Insider
- Location
- SAN DIEGO, CA
Filing Details
- Filing Date
- Apr 20, 2026
- Transaction Date
- Apr 17, 2026
- Accession Number
- 0001193125-26-164014
- Form Type
- 4
- Net Trading Amount
- -$161.6K
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Apr 17, 2026 | BLTE common stock | 32 | $158.46 | Sale | $5.1K |
| Apr 17, 2026 | BLTE common stock | 52 | $159.38 | Sale | $8.3K |
| Apr 17, 2026 | BLTE common stock | 226 | $160.55 | Sale | $36.3K |
| Apr 17, 2026 | BLTE common stock | 274 | $161.41 | Sale | $44.2K |
| Apr 17, 2026 | BLTE common stock | 216 | $162.48 | Sale | $35.1K |
| Apr 17, 2026 | BLTE common stock | 200 | $163.32 | Sale | $32.7K |
Want live alerts when MATA NATHAN L. trades again?
Download Insider Trades to track BLTE, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)Each American depositary share represents one ordinary share, par value US$0.0001 per share, of the issuer.
- (F2)The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/10/2025.
- (F3)Represents the weighted average price of shares sold at prices that ranged from $158.09 to $158.89. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
- (F4)Represents the weighted average price of shares sold at prices that ranged from $159.07 to $159.995. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
- (F5)Represents the weighted average price of shares sold at prices that ranged from $160.00 to $160.995. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
- (F6)Represents the weighted average price of shares sold at prices that ranged from $161.01 to $161.92. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
- (F7)Represents the weighted average price of shares sold at prices that ranged from $162.01 to $162.55. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
- (F8)Represents the weighted average price of shares sold at prices that ranged from $163.27 to $163.38. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.